Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCAREPVTLTDADA8 65b0b7e3912bef38d51b547d Medicines https://www.sterispharma.com
{ "products": [ { "_id": "65c74dead1d01500d8c67c35", "fptag": "STERISHEALTHCAREPVTLTDADA8", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ATOVASTRIN AV 10/150 ", "description": "ATOVASTRIN AV 150 \nAtorvastatin (10mg), Aspirin (150mg)\nATOVASTRIN AV 150 is often used in the management of cardiovascular disease (CVD) risk factors. Atorvastatin, as previously described, is a statin medication that lowers cholesterol and reduces the risk of cardiovascular events. Aspirin, on the other hand, is an antiplatelet medication that helps prevent blood clots. ATOVASTRIN AV 150 \ncan be particularly effective in individuals with high risk of heart attacks, strokes, and other cardiovascular-related issues.\n\nATOVASTRIN AV 150 : How They Work Together\nAtorvastatin reduces the level of bad cholesterol (LDL) and triglycerides in the blood, while increasing the level of good cholesterol (HDL). It works by inhibiting the enzyme HMG-CoA reductase, which is involved in cholesterol synthesis in the liver.\nAspirin prevents blood clots by inhibiting the function of platelets, making it less likely for clots to form and cause a heart attack or stroke. It does this by irreversibly inhibiting the enzyme cyclooxygenase, which is necessary for the production of thromboxane, a molecule that stimulates platelet aggregation.\nATOVASTRIN AV 150 may be indicated for:\n\nPrimary prevention in individuals at high risk of cardiovascular disease but who have not yet developed symptoms or had an event. This includes people with multiple cardiovascular risk factors such as diabetes, high blood pressure, smoking, or a family history of heart disease.\nSecondary prevention in individuals who have already experienced a cardiovascular event such as a heart attack or stroke, or who have established cardiovascular disease, to reduce the risk of future events.\nConsiderations and Precautions\nBleeding Risk: Aspirin increases the risk of bleeding, so combining it with atorvastatin requires careful consideration of the patient's overall bleeding risk.\nLiver Function: Both medications can affect liver function, so monitoring liver enzymes is important when taking this combination.\nMuscle Symptoms: ATOVASTRIN AV 150 \ncan cause muscle symptoms. Adding aspirin does not necessarily increase this risk but monitoring for muscle pain or weakness is still important.\nGastrointestinal Effects: Aspirin can cause gastrointestinal irritation or ulcers. Using enteric-coated aspirin can help mitigate this risk.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now:\nhttps://www.sterisonline.com/product/atovastrin-av-150-133251\n", "price": 55.0, "discountamount": 17.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "HDL", "LDL", "order", "level", "ulcers", "people", "patient", "smoking", "strokes", "weakness", "molecule", "diabetes", "high risk", "platelets", "other hand", "monitoring", "production", "management", "blood clots", "thromboxane", "information", "individuals", "Precautions", "medications", "combination", "muscle pain", "Atorvastatin", "sterisonline", "sterispharma", "ATOVASTRIN AV", "heart disease", "triglycerides", "heart attacks", "liver enzymes", "future events", "Liver Function", "family history", "Considerations", "Muscle Symptoms", "bad cholesterol", "good cholesterol", "HMG-CoA reductase", "CVD) risk factors", "statin medication", "Primary prevention", "high blood pressure", "Secondary prevention", "platelet aggregation", "overall bleeding risk", "cardiovascular events", "enzyme cyclooxygenase", "careful consideration", "cholesterol synthesis", "enteric-coated aspirin", "cardiovascular disease", "antiplatelet medication", "Gastrointestinal Effects", "gastrointestinal irritation", "other cardiovascular-related issues", "multiple cardiovascular risk factors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 247, "imageuri": "https://bizimages.withfloats.com/actual/8a384ffb2d3e450e8d0827817b901d71.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/8a384ffb2d3e450e8d0827817b901d71.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-02-10T10:20:26.422Z", "updatedon": "2024-06-28T09:18:06Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/medicines/atovastrin-av-10-150-/247", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Atorvastatin (10mg), Aspirin (150mg)", "category": "Cardiology range", "tags": [ "atovastrin av 150 uses in hindi", "atovastrin av 150 price", "atovastrin av 150 dosage", "atovastrin av 150 buy online", "atovastrin av 150 benefits", "atovastrin av 150 manufacturer" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 12.0, "isnotforsale": false }, { "_id": "67a20968501e8cb4a536a601", "fptag": "STERISHEALTHCAREPVTLTDADA8", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIEMPAFLOZIN MET 12.5mg/ 1000mg ", "description": "GLIEMPAFLOZIN MET 12.5mg/1000mg is an advanced combination medication formulated for the management of Type 2 Diabetes Mellitus. This dual-action therapy helps improve glycemic control by reducing blood sugar levels through two complementary mechanisms. It is ideal for individuals who require a combination of SGLT2 inhibition and biguanide therapy for effective blood sugar regulation. Along with a proper diet and regular exercise, this medication aids in better diabetes management and reduces the risk of diabetes-related complications.\n\n \nKey Benefits:\n \n\n Effective Blood Sugar Control – Helps lower HbA1c levels.\nWeight Management – Empagliflozin aids in weight loss by eliminating excess glucose through urine.\nCardiovascular Benefits – Reduces the risk of heart disease in diabetic patients.\nImproves Insulin Sensitivity – Enhances the body's response to insulin.\nSupports Kidney Function – Empagliflozin helps protect kidney function by reducing strain on the nephrons.\nReduces the Risk of Hypoglycemia – Unlike some other diabetes treatments, this combination has a lower risk of causing low blood sugar episodes.\n \nHow Does It Work?\n \n\nEmpagliflozin works by blocking SGLT2 (Sodium-Glucose Co-Transporter-2) in the kidneys, leading to the excretion of excess glucose through urine.\nMetformin decreases hepatic glucose production, slows glucose absorption from the intestines, and enhances insulin sensitivity in peripheral tissues.\nTogether, these mechanisms ensure better glycemic control while reducing the burden on the pancreas and insulin production.\n \nDirections for Use:\n \n\n Dosage: Take as prescribed by your healthcare provider.\nTiming: Usually taken once or twice daily with meals to reduce gastrointestinal side effects.\nSwallow Whole: Do not crush, chew, or break the tablet.\nLifestyle Recommendations: Maintain a healthy diet, regular physical activity, and weight management for best results.\n \nSide Effects:\n \n\nWhile GLIEMPAFLOZIN MET 12.5mg/1000mg is well-tolerated, some individuals may experience mild to moderate side effects, such as:\n\nFrequent urination (due to Empagliflozin)\nDehydration and low blood pressure\nGastrointestinal issues like nausea, diarrhea, or stomach upset\nYeast infections (especially in women)\nVitamin B12 deficiency (due to prolonged Metformin use)\nWarning: In rare cases, it may cause lactic acidosis or diabetic ketoacidosis. Consult your doctor immediately if you experience severe weakness, dizziness, difficulty breathing, or chest pain.", "price": 420.0, "discountamount": 126.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "lower risk", "nephrons reduces", "reducing strain", "weight management", "diabetes management", "chest pain", "doctor immediately", "lactic acidosis", "rare cases", "prolonged metformin", "nausea diarrhea", "experience mild", "crush chew", "glycemic control", "mechanisms ensure", "peripheral tissues", "kidneys leading", "diabetes treatments", "hypoglycemia unlike", "bodys response", "heart disease", "weight loss", "medication aids", "regular exercise", "proper diet", "biguanide therapy", "sglt2 inhibition", "complementary mechanisms", "empagliflozin dehydration", "excess glucose", "eliminating excess glucose", "work empagliflozin works", "diabetic ketoacidosis consult", "frequent urination due", "moderate side effects", "gliempaflozin met 125mg1000mg", "results side effects", "healthcare provider timing", "insulin production directions", "enhances insulin sensitivity" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1368, "imageuri": "https://bizimages.withfloats.com/actual/94ea4aaf0e214bb8b33227866b2da4b3.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/94ea4aaf0e214bb8b33227866b2da4b3.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-04T12:34:48.916Z", "updatedon": "2025-02-04T12:42:08.879Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/medicines/gliempaflozin-met-12-5mg-1000mg-/1368", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin 12.5mg, Metformin Hydrochloride 1000mg", "category": "Diabetic Range", "tags": [ "Empagliflozin 10 mg Uses in Hindi", "Fixed dose combination of empagliflozin and linagliptin tablets", "Empagliflozin 25 mg Uses in Hindi", "Linagliptin 5 mg uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 12.0, "isnotforsale": false }, { "_id": "67a20895454bb300b3984b6c", "fptag": "STERISHEALTHCAREPVTLTDADA8", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIEMPAFLOZIN MET 5mg/ 1000mg ", "description": "GLIEMPAFLOZIN MET 5mg/1000mg is a combination medication formulated to manage type 2 diabetes mellitus (T2DM) effectively. It contains Empagliflozin (5mg) and Metformin Hydrochloride (1000mg), two powerful antidiabetic agents that work together to regulate blood sugar levels. This medication helps improve glycemic control, reduce insulin resistance, and lower the risk of diabetes-related complications when combined with a healthy diet and regular exercise.\n\n \n\nKey Benefits:\n \n\nEffective Blood Sugar Control – Regulates blood glucose levels by decreasing sugar production and enhancing excretion.\n\nWeight Management – Empagliflozin helps in weight reduction by promoting calorie loss through urinary glucose excretion.\n\nReduced Cardiovascular Risks – Lowers the risk of heart disease in diabetic patients.\n\nImproved Insulin Sensitivity – Enhances the body's response to insulin and reduces insulin resistance.\n\nSupports Kidney Function – Helps prevent diabetes-related kidney complications.\n\nLowers the Risk of Hypoglycemia – Unlike some other diabetes medications, it reduces the chances of sudden blood sugar drops.\n\n \nHow Does It Work?\n \n\nGLIEMPAFLOZIN MET 5mg/1000mg combines two distinct yet complementary mechanisms of action:\n\nEmpagliflozin (SGLT2 Inhibitor) – Blocks glucose reabsorption in the kidneys, causing excess sugar to be eliminated through urine, thereby lowering blood sugar levels.\n\nMetformin (Biguanide) – Works by decreasing hepatic glucose production, increasing insulin sensitivity, and reducing intestinal glucose absorption. This results in overall better glycemic control.\n\n \nDirections for Use:\n \n\nTake GLIEMPAFLOZIN MET 5mg/1000mg once or twice daily as directed by your healthcare provider.\n\nSwallow the tablet whole with water; do not crush or chew.\n\nIt is best taken with meals to minimize gastrointestinal side effects.\n\nFollow a balanced diet and engage in regular physical activity for optimal diabetes management.\n\nDo not skip doses or stop medication without consulting a doctor.\n\n \nSide Effects:\n \n\nAlthough GLIEMPAFLOZIN MET 5mg/1000mg is well-tolerated, some individuals may experience side effects such as:\n\nFrequent urination (due to glucose excretion)\n\nDehydration and electrolyte imbalances\n\nGastrointestinal issues – Nausea, vomiting, diarrhea, or stomach discomfort\n\nUrinary tract infections (UTIs)\n\nGenital infections (yeast infections)\n\nLactic acidosis (rare but serious) due to metformin accumulation\n\nLow blood pressure (hypotension)", "price": 125.0, "discountamount": 38.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "skip doses", "balanced diet", "complementary mechanisms", "hypoglycemia unlike", "bodys response", "heart disease", "weight reduction", "healthy diet", "diabetesrelated complications", "empagliflozin 5mg", "stop medication", "diabetes medications", "frequent urination due", "optimal diabetes management", "combination medication formulated", "glucose excretion dehydration", "experience side effects", "doctor side effects", "regular physical activity", "healthcare provider swallow", "gliempaflozin met 5mg1000mg", "glycemic control directions", "promoting calorie loss", "decreasing sugar production", "powerful antidiabetic agents", "metformin hydrochloride 1000mg" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1367, "imageuri": "https://bizimages.withfloats.com/actual/8bee67a620504834bdc550e56fcd9e07.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/8bee67a620504834bdc550e56fcd9e07.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-04T12:31:17.659Z", "updatedon": "2025-03-27T09:43:35.69Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/medicines/gliempaflozin-met-5mg-1000mg-/1367", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin (5mg) , Metformin Hydrochloride (1000mg)", "category": "Diabetic Range", "tags": [ "empagliflozin/metformin 5 mg/1000 mg", "empagliflozin/metformin 5 mg/500 mg", "empagliflozin + metformin combination brand name", "Empagliflozin and metformin hydrochloride tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 12.0, "isnotforsale": false }, { "_id": "6720b1119164aa65cf5cdbe9", "fptag": "STERISHEALTHCAREPVTLTDADA8", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "AVANA FINE 100 ", "description": "AVANA FINE 100 is a prescription medication primarily used to treat erectile dysfunction (ED) in men. Containing Avanafil (100 mg) as the active ingredient, it belongs to the class of drugs known as phosphodiesterase type 5 (PDE5) inhibitors. AVANA FINE 100 is designed to help men achieve and maintain an erection by increasing blood flow to the penis when sexually stimulated. It is known for its fast action, typically working within 15 to 30 minutes, and can be taken shortly before engaging in sexual activity, making it a convenient and effective solution for those dealing with ED.\n\n \nKey Benefits:\n \n\nFast-Acting Formula: Avanafil works faster than many other ED medications, with effects typically starting within 15 minutes of ingestion. This allows for more spontaneity in sexual activity.\n\nEffective for Erectile Dysfunction: AVANA FINE 100 is proven to be effective in helping men achieve and maintain a firmer, longer-lasting erection when sexually stimulated, thereby improving sexual performance and satisfaction.\n\nLong-Lasting Results: The effects of AVANA FINE 100 can last for up to 6 hours, providing ample time for sexual activity.\n\nImproved Confidence and Quality of Life: For men struggling with ED, AVANA FINE 100 offers a reliable solution that can restore confidence and improve overall quality of life, including intimate relationships.\n\nReduced Side Effects: Avanafil is known for its lower incidence of side effects compared to other PDE5 inhibitors, making it a safer option for many users.\n\n \nHow Does It Work?\n \n\nAVANA FINE 100 works by inhibiting the enzyme phosphodiesterase type 5 (PDE5). PDE5 is responsible for regulating blood flow in the penis. By inhibiting this enzyme, Avanafil enhances the effect of nitric oxide, a natural chemical released during sexual stimulation. Nitric oxide helps relax the smooth muscles in the penis, allowing more blood to flow into the penile tissues. This increased blood flow helps a man achieve and maintain an erection sufficient for sexual activity.\n\nIt is important to note that AVANA FINE 100 only works when there is sexual arousal. It does not cause an erection on its own without stimulation.\n\n \nDirections for Use:\n \n\nDosage: The recommended starting dose of AVANA FINE 100 is one tablet (100 mg) taken orally as needed. It should be taken approximately 15 to 30 minutes before engaging in sexual activity.\nFood and Drink: AVANA FINE 100 can be taken with or without food. However, taking it with a high-fat meal may delay its onset of action.\nTiming: Avoid taking more than one dose in a 24-hour period. It is best to follow your doctor's guidance regarding how frequently to use this medication.\nAlcohol: It is advisable to avoid excessive alcohol consumption while taking this medication, as it may increase the risk of side effects like dizziness or low blood pressure.\n \nSide Effects:\n \n\nWhile AVANA FINE 100 is generally well-tolerated, some users may experience side effects. Common side effects include:\n\nHeadache: A common side effect due to the increased blood flow caused by the medication.\nFlushing: Some users may experience a warm or flushed sensation in the face or upper body.\nNasal Congestion: Mild nasal stuffiness or congestion can occur.\nDizziness: A sense of lightheadedness or dizziness, especially when standing up quickly.\nBack Pain or Muscle Aches: Some individuals report mild muscle aches, including back pain.\n \nLess Common but Serious Side Effects:\n \n\nVision Changes: In rare cases, some men may experience blurred vision or color changes in vision (such as a blue tinge to objects or difficulty distinguishing between blue and green).\nHearing Loss: A rare but serious side effect can include sudden hearing loss.\nProlonged Erection (Priapism): If an erection lasts more than 4 hours, seek immediate medical attention to avoid permanent damage to the penis.\nAllergic Reactions: In rare cases, some people may experience an allergic reaction, which may include symptoms like hives, swelling, or difficulty breathing.", "price": 245.0, "discountamount": 74.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "4 hours", "one dose", "Back Pain", "15 minutes", "blue tinge", "rare cases", "upper body", "one tablet", "ample time", "blood flow", "AVANA FINE", "many users", "fast action", "Less Common", "nitric oxide", "Key Benefits", "color changes", "high-fat meal", "starting dose", "up to 6 hours", "blurred vision", "Vision Changes", "24-hour period", "sexual arousal", "penile tissues", "smooth muscles", "overall quality", "lower incidence", "sexual activity", "permanent damage", "Nasal Congestion", "natural chemical", "15 to 30 minutes", "PDE5) inhibitors", "flushed sensation", "reliable solution", "active ingredient", "mild muscle aches", "Prolonged Erection", "sexual stimulation", "Allergic Reactions", "sexual performance", "effective solution", "common side effect", "low blood pressure", "Improved Confidence", "Fast-Acting Formula", "serious side effect", "sudden hearing loss", "Long-Lasting Results", "erectile dysfunction", "Reduced Side Effects", "other PDE5 inhibitors", "Mild nasal stuffiness", "intimate relationships", "prescription medication", "phosphodiesterase type 5", "many other ED medications", "immediate medical attention", "enzyme phosphodiesterase type", "excessive alcohol consumption", "firmer, longer-lasting erection" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1129, "imageuri": "https://bizimages.withfloats.com/actual/d7b54210cd7242158de1253a2120bbb0.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/d7b54210cd7242158de1253a2120bbb0.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-10-29T09:55:29.231Z", "updatedon": "2024-10-30T09:08:08.611Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/medicines/avana-fine-100-/1129", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Avanafil (100 mg)", "category": "Urology Range", "tags": [ "Avanafil 100 mg price in India", "Avanafil tablets 100mg price", "Avanafil tablets 100mg Uses in Hindi", "Avanafil Tablet price", "Avanafil Tablets 100mg online" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 12.0, "isnotforsale": false }, { "_id": "665b08e37247ae19c4823397", "fptag": "STERISHEALTHCAREPVTLTDADA8", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "QT-PINE SR 100 ", "description": "QT-PINE SR 100\nQuetiapine Fumarate Susntained Release \nQT-PINE SR 100, containing Quetiapine Fumarate Sustained Release 100mg, is an atypical antipsychotic medication used to treat various mental health conditions. This article provides a comprehensive overview of Quetiapine Fumarate Sustained Release (100mg), covering its uses, dosage, side effects, price, and concluding insights to offer a thorough understanding of this medication.\n\nUses of Quetiapine Fumarate Sustained Release\nQuetiapine Fumarate is primarily prescribed for the treatment of several psychiatric conditions. The primary uses include:\n\nSchizophrenia: Quetiapine is effective in managing the symptoms of schizophrenia, including hallucinations, delusions, and disorganized thinking.\nBipolar Disorder: It is used to treat both manic and depressive episodes of bipolar disorder, helping to stabilize mood swings.\nMajor Depressive Disorder (MDD): When combined with other antidepressants, Quetiapine can help treat treatment-resistant depression.\nGeneralized Anxiety Disorder (GAD): Quetiapine is sometimes prescribed off-label to manage symptoms of GAD.\nMechanism of Action\nQuetiapine works by affecting various neurotransmitters in the brain, particularly dopamine and serotonin. By modulating these chemical messengers, Quetiapine helps alleviate the symptoms of mental health disorders, promoting mood stabilization and reducing psychotic symptoms.\n\nDosage and Administration\nThe dosage of Quetiapine Fumarate is individualized based on the patient’s condition, response to the medication, and the presence of any co-existing medical issues. Here is a general guideline for dosage:\n\nSchizophrenia:\nInitial Dose: The typical starting dose for adults is 50-100mg once daily, usually taken in the evening.\nMaintenance Dose: Depending on the patient's response, the dose can be gradually increased to 400-800mg per day, taken once daily or in divided doses.\nBipolar Disorder:\nManic Episodes: The initial dose is usually 100mg once daily, with gradual increases up to 400-800mg per day.\nDepressive Episodes: The initial dose is typically 50mg once daily, with gradual increases to 300mg per day.\nMajor Depressive Disorder:\nInitial Dose: The typical starting dose is 50mg once daily, with gradual increases to 150-300mg per day, depending on the patient's response.\nAdministration Instructions\nQuetiapine should be taken as prescribed by a healthcare provider. It is typically taken once daily, preferably in the evening, with or without food. Patients should follow the prescribed regimen closely and avoid abrupt discontinuation to prevent withdrawal symptoms and a sudden worsening of symptoms.\n\nSide Effects\nLike all medications, Quetiapine can cause side effects, although not everyone will experience them. The most common side effects include:\n\nDrowsiness and Sedation: Due to its sedative properties, drowsiness and sedation are common.\nWeight Gain: Significant weight gain can occur, which may lead to metabolic issues such as diabetes and high cholesterol.\nDry Mouth: Many patients report a dry mouth while taking this medication.\nConstipation: Gastrointestinal disturbances such as constipation can occur.\nDizziness: Dizziness, especially when standing up quickly, is a common side effect.\nSerious Side Effects\nWhile rare, serious side effects can occur and require immediate medical attention. These include:\n\n\n Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \nCALL/WHATSAPP: 7877551268, 7849827488\nBUY NOW\nhttps://www.sterisonline.com/product/qt-pine-sr-100-134091", "price": 81.0, "discountamount": 25.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "GMP", "BUY", "day", "WHO", "GAD", "MDD", "50mg", "food", "300mg", "EMAIL", "group", "brain", "label", "India", "Asthma", "Action", "adults", "dosage", "article", "regimen", "benefit", "mission", "evening", "Urology", "company", "everyone", "Oncology", "50-100mg", "diabetes", "Sedation", "February", "response", "dopamine", "presence", "delusions", "Dry Mouth", "serotonin", "400-800mg", "Mechanism", "Dizziness", "customers", "medicines", "qt-pine-sr", "wide array", "Drowsiness", "Cardiology", "commitment", "QT-PINE SR", "Nephrology", "Gynecology", "Pediatrics", "mood swings", "Navi Mumbai", "convenience", "Dermatology", "medications", "information", "Orthopedics", "Dental care", "Initial Dose", "primary uses", "Sterispharma", "sterisonline", "varied needs", "Constipation", "divided doses", "broad demands", "Many patients", "home delivery", "CALL/WHATSAPP", "Endocrinology", "Schizophrenia", "certifications", "Manic Episodes", "hallucinations", "rare conditions", "online pharmacy", "metabolic issues", "Maintenance Dose", "Bipolar Disorder", "General Medicine", "Nasal conditions", "Gastroenterology", "high cholesterol", "sudden worsening", "gradual increases", "general guideline", "medical community", "affordable prices", "high-quality drugs", "Respiratory issues", "psychotic symptoms", "common side effect", "mood stabilization", "advanced treatments", "rigorous guidelines", "withdrawal symptoms", "sedative properties", "depressive episodes", "chemical messengers", "healthcare provider", "healthcare products", "concluding insights", "healthcare industry", "various health areas", "expert professionals", "typical starting dose", "other antidepressants", "disorganized thinking", "comprehensive overview", "thorough understanding", "abrupt discontinuation", "mental health disorders", "Significant weight gain", "existing medical issues", "pharmaceutical industry", "extensive product lineup", "basic health necessities", "Steris Healthcare Pvt Ltd", "Major Depressive Disorder", "various neurotransmitters", "rare, serious side effects", "Administration Instructions", "Anti-infectives/antibiotics", "immediate medical attention", "Generalized Anxiety Disorder", "Gastrointestinal disturbances", "several psychiatric conditions", "treatment-resistant depression", "various mental health conditions", "atypical antipsychotic medication", "Quetiapine Fumarate Susntained Release", "Quetiapine Fumarate Sustained Release 100mg" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1066, "imageuri": "https://bizimages.withfloats.com/actual/1c9ca708a40a442c88f961bbc2cb7ffa.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/1c9ca708a40a442c88f961bbc2cb7ffa.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-01T11:41:23.022Z", "updatedon": "2024-06-29T06:05:52Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/medicines/qt-pine-sr-100-/1066", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Quetiapine Fumarate Susntained Release", "category": "Neurology Range", "tags": [ "Qutipin", "Q-Mind", "qutipin sr 100 uses", "qutipin sr 100 side effects", "qutipin sr 100 substitute", "qutipin sr 100 price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 12.0, "isnotforsale": false }, { "_id": "662cc0f518870a17183d4de0", "fptag": "STERISHEALTHCAREPVTLTDADA8", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TENELIGOLD PIO 20/15 ", "description": "TENELIGOLD PIO 20/15 \nTeneligliptin & Pioglitazone\nIntroduction\nAs the landscape of Type 2 diabetes treatment continues to evolve, combining different therapeutic agents to target various pathways has become a key strategy in managing the disease more effectively. TENELIGOLD PIO 20/15, which combines Teneligliptin (20mg) and Pioglitazone (15mg), offers a comprehensive approach to improve glycemic control. This article explores the benefits, mechanisms, and practical usage of this combination therapy, underscoring its potential in enhancing diabetes care.\n\nUnderstanding the Active Ingredients\nTeneligliptin: A Potent DPP-4 Inhibitor\nTeneligliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, works by prolonging the action of incretin hormones, which are vital for insulin secretion in response to meals. By inhibiting the enzyme that breaks down these hormones, Teneligliptin allows for increased insulin release and decreased glucagon production, particularly after eating, leading to improved control of postprandial glucose levels.\n\nPioglitazone: A Thiazolidinedione\nPioglitazone falls under the class of thiazolidinediones and primarily works by enhancing insulin sensitivity in peripheral tissue, such as muscle and fat, and inhibiting hepatic gluconeogenesis. This mechanism helps to lower insulin resistance and reduce blood glucose levels. Pioglitazone also has benefits in terms of potentially improving lipid profiles and reducing inflammation.\n\nThe Synergistic Benefits of TENELIGOLD PIO 20/15\nComprehensive Glycemic Control\nThe combination of Teneligliptin and Pioglitazone addresses both insulin secretion and insulin resistance—a dual approach that is often necessary for patients with Type 2 diabetes who experience complex metabolic dysfunctions. This synergy not only helps in achieving better control over fasting and postprandial blood sugar levels but also improves overall metabolic health.\n\nMinimized Risk of Hypoglycemia\nWhile many diabetes treatments increase the risk of hypoglycemia, the combination of Teneligliptin and Pioglitazone carries a lower risk. Teneligliptin enhances insulin secretion in a glucose-dependent manner, reducing the likelihood of insulin-induced hypoglycemia. Pioglitazone does not directly stimulate insulin release, which further mitigates this risk.\n\nPositive Effects on Lipid Profile and Cardiovascular Risk\nPioglitazone has been noted for its beneficial effects on triglycerides and HDL cholesterol levels. When combined with Teneligliptin, TENELIGOLD PIO 20/15 not only manages blood glucose but also contributes to a healthier lipid profile, which is crucial for reducing cardiovascular risk in diabetic patients.\n\nIdeal Candidates for TENELIGOLD PIO 20/15\nThis medication is particularly suitable for Type 2 diabetes patients who:\n\nHave struggled to control blood sugar levels with single-drug therapies.\nAre particularly sensitive to the side effects of other diabetes medications.\nMay benefit from the cardiovascular and lipid profile improvements offered by Pioglitazone.\nDosage and Administration\nTENELIGOLD PIO 20/15 is typically prescribed as one tablet per day, which can be taken with or without food. It is important to monitor liver function before and during treatment with Pioglitazone, as it can affect liver enzymes and requires careful monitoring.\n\nPotential Side Effects and Considerations\nWhile TENELIGOLD PIO 20/15 is effective for many, it does carry potential side effects:\n\nRisk of weight gain and fluid retention, primarily associated with Pioglitazone.\nPotential for increased risk of bone fractures and bladder cancer with long-term use of Pioglitazone.\nMild gastrointestinal issues or respiratory infections related to Teneligliptin.\n For further information: \n EMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668 \nhttps://www.sterisonline.com/product/teneligold-pio-20-15-134077", "price": 149.0, "discountamount": 44.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "fat", "day", "food", "meals", "terms", "class", "EMAIL", "muscle", "action", "Dosage", "disease", "fasting", "synergy", "article", "response", "improved", "landscape", "mechanisms", "lower risk", "one tablet", "likelihood", "weight gain", "information", "inflammation", "sterisonline", "key strategy", "sterispharma", "Introduction", "Pioglitazone", "dual approach", "long-term use", "CALL/WHATSAPP", "Teneligliptin", "diabetes care", "triglycerides", "liver enzymes", "Minimized Risk", "Considerations", "bladder cancer", "bone fractures", "Administration", "liver function", "increased risk", "teneligold-pio", "lipid profiles", "TENELIGOLD PIO", "fluid retention", "practical usage", "insulin release", "Ideal Candidates", "DPP-4) inhibitor", "Positive Effects", "various pathways", "diabetic patients", "peripheral tissue", "incretin hormones", "insulin secretion", "thiazolidinediones", "Active Ingredients", "beneficial effects", "careful monitoring", "insulin resistance", "combination therapy", "glucagon production", "A Thiazolidinedione", "insulin sensitivity", "Cardiovascular Risk", "blood glucose levels", "single-drug therapies", "Potent DPP-4 Inhibitor", "Potential Side Effects", "HDL cholesterol levels", "comprehensive approach", "respiratory infections", "dipeptidyl peptidase-4", "hepatic gluconeogenesis", "healthier lipid profile", "overall metabolic health", "The Synergistic Benefits", "many diabetes treatments", "glucose-dependent manner", "Type 2 diabetes patients", "Type 2 diabetes treatment", "lipid profile improvements", "other diabetes medications", "postprandial glucose levels", "different therapeutic agents", "insulin-induced hypoglycemia", "Mild gastrointestinal issues", "Comprehensive Glycemic Control", "complex metabolic dysfunctions", "postprandial blood sugar levels" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 938, "imageuri": "https://bizimages.withfloats.com/actual/e2cd2b3d82e941ecbb6ff1c081bd2108.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/e2cd2b3d82e941ecbb6ff1c081bd2108.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-27T09:10:13.536Z", "updatedon": "2024-04-27T09:10:13.536Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/medicines/teneligold-pio-20-15-/938", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Teneligliptin & Pioglitazone", "category": "Diabetic Range", "tags": [ "Joten P", "Zita-Pio", "Tenepride P", "Zita Plus-Pio", "Tendia-P", "Tencrine P" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 0.0, "isnotforsale": false }, { "_id": "662b7f3f49be7218fcf50074", "fptag": "STERISHEALTHCAREPVTLTDADA8", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PIOSTERIS 15 ", "description": "PIOSTERIS 15 \nPioglitazone (15mg)\nIntroduction:\nDiabetes mellitus is a prevalent chronic condition that requires effective management to prevent complications and improve quality of life. Among the arsenal of medications available for the treatment of type 2 diabetes mellitus (T2DM), Pioglitazone has emerged as a valuable therapeutic option. PIOSTERIS 15, featuring Pioglitazone at a dosage of 15mg, represents a significant advancement in the management of T2DM. This article explores the features, efficacy, safety profile, and clinical implications of PIOSTERIS 15 in diabetes care.\n\nUnderstanding Pioglitazone:\nPioglitazone belongs to the class of thiazolidinediones (TZDs), which act primarily by improving insulin sensitivity in peripheral tissues such as adipose tissue, skeletal muscle, and liver. By activating peroxisome proliferator-activated receptor gamma (PPAR-γ) receptors, Pioglitazone enhances glucose uptake and utilization, leading to improved glycemic control in patients with T2DM.\n\nKey Features of PIOSTERIS 15:\nPIOSTERIS 15 is a pharmaceutical formulation containing Pioglitazone at a standardized dosage of 15mg per tablet. This dosage strength provides clinicians with the flexibility to tailor treatment regimens to individual patient needs, ensuring optimal glycemic control. The formulation of PIOSTERIS 15 ensures consistency and reliability in dosing, facilitating effective diabetes management.\n For further information: \n EMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668 \nhttps://www.sterisonline.com/product/piosteris-15-133429", "price": 55.0, "discountamount": 16.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "T2DM", "15mg", "TZDs", "EMAIL", "class", "liver", "dosing", "tablet", "arsenal", "article", "quality", "improved", "efficacy", "patients", "PIOSTERIS", "clinicians", "flexibility", "consistency", "reliability", "information", "medications", "utilization", "sterispharma", "Introduction", "sterisonline", "Key Features", "Pioglitazone", "CALL/WHATSAPP", "complications", "diabetes care", "safety profile", "glucose uptake", "adipose tissue", "dosage strength", "skeletal muscle", "PPAR-γ) receptors", "treatment regimens", "thiazolidinediones", "peripheral tissues", "insulin sensitivity", "standardized dosage", "effective management", "clinical implications", "significant advancement", "optimal glycemic control", "type 2 diabetes mellitus", "individual patient needs", "pharmaceutical formulation", "valuable therapeutic option", "prevalent chronic condition", "effective diabetes management", "peroxisome proliferator-activated receptor gamma" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 921, "imageuri": "https://bizimages.withfloats.com/actual/e1d62f5f49b1449c94fce806a62fae5b.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/e1d62f5f49b1449c94fce806a62fae5b.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-26T10:17:35.628Z", "updatedon": "2024-04-26T10:17:35.628Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/medicines/piosteris-15-/921", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Pioglitazone (15mg)", "category": "Diabetic Range", "tags": [ "Pioz", "Pioglit", "Piosys", "Pioglar", "Pionorm", "Path", "Glitaris", "Piokind", "Piomed", "Piopod" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 0.0, "isnotforsale": false }, { "_id": "661148c0b6464a16cca49f38", "fptag": "STERISHEALTHCAREPVTLTDADA8", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "EPSTATE ER 150 ", "description": "EPSTATE ER 150\nEpalrestat Tablets ER (50mg)\nEPSTATE ER 150 is a pharmaceutical formulation designed to address the needs of patients requiring management of severe, chronic pain. The \"ER\" in its name stands for extended release, indicating that this medication is formulated to release its active ingredient slowly over time, providing long-lasting pain relief. The 150 mg dosage suggests a potent strength, tailored for patients who may have developed tolerance to lower doses of pain medication or who need a higher dose to control their pain effectively.\n\nThis medication is likely an opioid or a strong analgesic, given its extended-release form and the typical use of such dosages in pain management. It works by binding to specific receptors in the brain and nervous system to reduce the perception of pain. The extended-release formulation of EPSTATE ER 150 ensures a controlled release of the active ingredient, maintaining stable blood levels of the medication and providing consistent pain relief over an extended period. Patients prescribed EPSTATE ER 150 must follow their healthcare provider's instructions closely, considering the potential for dependency and other risks associated with long-term use of potent analgesics. It is essential for managing chronic conditions where pain is a significant symptom, offering patients an improved quality of life through sustained symptom management.\nFor further information please contact:\ninfo@sterispharma.com / contact@sterispharma.com\ncall/whatsapp: 8209542042, 8955945010, 6377716668\norder now: \nhttps://www.sterisonline.com/product/epstate-sr-150-133910\n\n\n\n\n\n\n\n", "price": 189.0, "discountamount": 56.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "sr", "name", "life", "time", "order", "needs", "lower", "doses", "brain", "opioid", "dosages", "patients", "potential", "tolerance", "dependency", "EPSTATE ER", "perception", "higher dose", "typical use", "information", "other risks", "sterisonline", "instructions", "sterispharma", "long-term use", "150 mg dosage", "nervous system", "extended period", "pain medication", "pain management", "potent strength", "improved quality", "extended release", "strong analgesic", "active ingredient", "potent analgesics", "specific receptors", "controlled release", "chronic conditions", "healthcare provider", "significant symptom", "lasting pain relief", "stable blood levels", "severe, chronic pain", "Epalrestat Tablets ER", "extended-release form", "consistent pain relief", "pharmaceutical formulation", "sustained symptom management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1182, "imageuri": "https://bizimages.withfloats.com/actual/0697e9138a29461eab3f7b618b2cb069.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/0697e9138a29461eab3f7b618b2cb069.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-06T13:06:08.485Z", "updatedon": "2024-06-18T12:42:01.667Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/medicines/epstate-er-150-/1182", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Epalrestat Tablets ER (50mg)", "category": "Diabetic Range", "tags": [ "Epstate er 150", "Aldonil", "Alrista", "Eparel", "Epo", "Palestat", "Restat", "Aristat", "Epalpex", "Aldorace", "Dinrest" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 12.0, "isnotforsale": false }, { "_id": "65d5b40d5f72731e00bc5c49", "fptag": "STERISHEALTHCAREPVTLTDADA8", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPA 3D 10/100/500 SR ", "description": "GLIDAPA 3D 10/100/500 SR \nDapaflozin 10 mg, Sitagliptin 100 mg & Metformin SR 500 mg\nDapagliflozin belongs to a class of medications called sodium-glucose co-transporter 2 (SGLT2) inhibitors. It works by helping the kidneys remove glucose from the bloodstream through the urine, thereby lowering blood sugar levels. Dapagliflozin is typically taken orally once daily.\nSitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by increasing the levels of incretin hormones in the body, which stimulate the pancreas to produce more insulin and reduce the liver's production of glucose. Sitagliptin is usually taken orally once daily.\nMetformin SR is a biguanide medication that helps lower blood sugar levels by decreasing the amount of glucose produced by the liver and improving insulin sensitivity in the body's cells. Metformin SR stands for sustained-release, meaning it releases the medication into the body gradually over time, allowing for once-daily dosing and potentially reducing gastrointestinal side effects compared to immediate-release formulations.\nSteris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 5 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.\nFor further information please contact:\ninfo@sterispharma.com / contact@sterispharma.com\ncall/whatsapp: 8209542042, 8955945010, 6377716668\norder now:\nhttps://www.sterisonline.com/product/glidapa-3d-10-100-500-sr-134215", "price": 575.0, "discountamount": 173.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "Top", "May", "body", "time", "order", "urine", "liver", "cells", "class", "amount", "kidneys", "glucose", "pancreas", "Pharmacy", "portfolio", "PAN India", "production", "GLIDAPA 3D", "Sitagliptin", "transporter", "Railway use", "new product", "bloodstream", "information", "medications", "Last 5 years", "sterisonline", "Metformin SR", "sterispharma", "similar pace", "daily dosing", "750+ Products", "Dapagliflozin", "Government use", "medicine supply", "Steris medicine", "Chronic Therapy", "DPP-4) inhibitor", "Dapaflozin 10 mg", "Reputed Hospitals", "sustained-release", "incretin hormones", "blood sugar levels", "insulin sensitivity", "biguanide medication", "leading manufacturers", "high quality medicine", "dipeptidyl peptidase-4", "WHO-GMP Approved Plants", "Steris Healthcare Pvt. Ltd.", "16+ Super Specialty Segments", "Legal manufacturing contracts", "gastrointestinal side effects", "Leading Pharmaceutical Company", "immediate-release formulations", "1000+ Business Franchise Partners" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 793, "imageuri": "https://bizimages.withfloats.com/actual/18b7eba50d664dd88b49297d8fd6605d.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/18b7eba50d664dd88b49297d8fd6605d.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-02-21T08:27:57.896Z", "updatedon": "2024-03-05T12:18:25Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/medicines/glidapa-3d-10-100-500-sr-/793", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Dapaflozin 10 mg, Sitagliptin 100 mg & Metformin SR 500 mg", "category": "Diabetic Range ", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 12.0, "isnotforsale": false }, { "_id": "65d5a3801847861c10522fd8", "fptag": "STERISHEALTHCAREPVTLTDADA8", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "EPSTATE SR 150 ", "description": "EPSTATE SR 150 \nEpalrestat Tablets ER (50mg)\nEpalrestat is a pharmaceutical drug used primarily in the treatment of diabetic neuropathy, a type of nerve damage that can occur in people with diabetes. It belongs to a class of medications known as aldose reductase inhibitors.\nAldose reductase is an enzyme involved in the metabolism of glucose, and its inhibition can help prevent or alleviate some of the complications associated with diabetes, such as neuropathy. By inhibiting aldose reductase, epalrestat helps reduce the accumulation of sorbitol, a sugar alcohol that can build up in nerves and other tissues in people with diabetes, leading to nerve damage.\nSteris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 5 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.\nFor further information please contact:\ninfo@sterispharma.com / contact@sterispharma.com\ncall/whatsapp: 7877551268,7849827488\norder now:\nhttps://www.sterisonline.com/product/epstate-sr-150-133910", "price": 189.0, "discountamount": 57.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "Top", "May", "type", "class", "order", "nerves", "enzyme", "people", "glucose", "Pharmacy", "sorbitol", "diabetes", "portfolio", "PAN India", "treatment", "inhibition", "metabolism", "EPSTATE SR", "medications", "new product", "information", "Railway use", "Last 5 years", "sterisonline", "nerve damage", "accumulation", "sterispharma", "similar pace", "750+ Products", "other tissues", "sugar alcohol", "complications", "Government use", "medicine supply", "Steris medicine", "Chronic Therapy", "Reputed Hospitals", "diabetic neuropathy", "pharmaceutical drug", "Epalrestat Tablets ER", "high quality medicine", "leading manufacturers", "WHO-GMP Approved Plants", "aldose reductase inhibitors", "Steris Healthcare Pvt. Ltd.", "16+ Super Specialty Segments", "Legal manufacturing contracts", "Leading Pharmaceutical Company", "1000+ Business Franchise Partners" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 778, "imageuri": "https://bizimages.withfloats.com/actual/7d729a3ee140477599c9a510f251ccb2.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/7d729a3ee140477599c9a510f251ccb2.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-02-21T07:17:20.279Z", "updatedon": "2024-06-28T11:48:20Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/medicines/epstate-sr-150-/778", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Epalrestat Tablets ER (50mg)", "category": "Diabetic Range ", "tags": [ "Epalrestat side effects", "Epalrestat tablets Uses in Hindi", "Epalrestat 50 mg side effects", "Epalrestat 150 mg Uses in Hindi", "Epalrestat dose", "Epalrestat Tablets ER (50mg)" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": "", "gstslab": 12.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 10, "query": null, "floatingpoint": null }

Still searching for
10 15 mg?

Request a Free Callback for Expert Support

244 results found
  • Afghanistan+93
  • Albania+355
  • Algeria+213
  • American Samoa+1
  • Andorra+376
  • Angola+244
  • Anguilla+1
  • Antigua & Barbuda+1
  • Argentina+54
  • Armenia+374
  • Aruba+297
  • Ascension Island+247
  • Australia+61
  • Austria+43
  • Azerbaijan+994
  • Bahamas+1
  • Bahrain+973
  • Bangladesh+880
  • Barbados+1
  • Belarus+375
  • Belgium+32
  • Belize+501
  • Benin+229
  • Bermuda+1
  • Bhutan+975
  • Bolivia+591
  • Bosnia & Herzegovina+387
  • Botswana+267
  • Brazil+55
  • British Indian Ocean Territory+246
  • British Virgin Islands+1
  • Brunei+673
  • Bulgaria+359
  • Burkina Faso+226
  • Burundi+257
  • Cambodia+855
  • Cameroon+237
  • Canada+1
  • Cape Verde+238
  • Caribbean Netherlands+599
  • Cayman Islands+1
  • Central African Republic+236
  • Chad+235
  • Chile+56
  • China+86
  • Christmas Island+61
  • Cocos (Keeling) Islands+61
  • Colombia+57
  • Comoros+269
  • Congo - Brazzaville+242
  • Congo - Kinshasa+243
  • Cook Islands+682
  • Costa Rica+506
  • Croatia+385
  • Cuba+53
  • Curaçao+599
  • Cyprus+357
  • Czechia+420
  • Côte d’Ivoire+225
  • Denmark+45
  • Djibouti+253
  • Dominica+1
  • Dominican Republic+1
  • Ecuador+593
  • Egypt+20
  • El Salvador+503
  • Equatorial Guinea+240
  • Eritrea+291
  • Estonia+372
  • Eswatini+268
  • Ethiopia+251
  • Falkland Islands+500
  • Faroe Islands+298
  • Fiji+679
  • Finland+358
  • France+33
  • French Guiana+594
  • French Polynesia+689
  • Gabon+241
  • Gambia+220
  • Georgia+995
  • Germany+49
  • Ghana+233
  • Gibraltar+350
  • Greece+30
  • Greenland+299
  • Grenada+1
  • Guadeloupe+590
  • Guam+1
  • Guatemala+502
  • Guernsey+44
  • Guinea+224
  • Guinea-Bissau+245
  • Guyana+592
  • Haiti+509
  • Honduras+504
  • Hong Kong SAR China+852
  • Hungary+36
  • Iceland+354
  • India+91
  • Indonesia+62
  • Iran+98
  • Iraq+964
  • Ireland+353
  • Isle of Man+44
  • Israel+972
  • Italy+39
  • Jamaica+1
  • Japan+81
  • Jersey+44
  • Jordan+962
  • Kazakhstan+7
  • Kenya+254
  • Kiribati+686
  • Kosovo+383
  • Kuwait+965
  • Kyrgyzstan+996
  • Laos+856
  • Latvia+371
  • Lebanon+961
  • Lesotho+266
  • Liberia+231
  • Libya+218
  • Liechtenstein+423
  • Lithuania+370
  • Luxembourg+352
  • Macao SAR China+853
  • Madagascar+261
  • Malawi+265
  • Malaysia+60
  • Maldives+960
  • Mali+223
  • Malta+356
  • Marshall Islands+692
  • Martinique+596
  • Mauritania+222
  • Mauritius+230
  • Mayotte+262
  • Mexico+52
  • Micronesia+691
  • Moldova+373
  • Monaco+377
  • Mongolia+976
  • Montenegro+382
  • Montserrat+1
  • Morocco+212
  • Mozambique+258
  • Myanmar (Burma)+95
  • Namibia+264
  • Nauru+674
  • Nepal+977
  • Netherlands+31
  • New Caledonia+687
  • New Zealand+64
  • Nicaragua+505
  • Niger+227
  • Nigeria+234
  • Niue+683
  • Norfolk Island+672
  • North Korea+850
  • North Macedonia+389
  • Northern Mariana Islands+1
  • Norway+47
  • Oman+968
  • Pakistan+92
  • Palau+680
  • Palestinian Territories+970
  • Panama+507
  • Papua New Guinea+675
  • Paraguay+595
  • Peru+51
  • Philippines+63
  • Poland+48
  • Portugal+351
  • Puerto Rico+1
  • Qatar+974
  • Romania+40
  • Russia+7
  • Rwanda+250
  • Réunion+262
  • Samoa+685
  • San Marino+378
  • Saudi Arabia+966
  • Senegal+221
  • Serbia+381
  • Seychelles+248
  • Sierra Leone+232
  • Singapore+65
  • Sint Maarten+1
  • Slovakia+421
  • Slovenia+386
  • Solomon Islands+677
  • Somalia+252
  • South Africa+27
  • South Korea+82
  • South Sudan+211
  • Spain+34
  • Sri Lanka+94
  • St. Barthélemy+590
  • St. Helena+290
  • St. Kitts & Nevis+1
  • St. Lucia+1
  • St. Martin+590
  • St. Pierre & Miquelon+508
  • St. Vincent & Grenadines+1
  • Sudan+249
  • Suriname+597
  • Svalbard & Jan Mayen+47
  • Sweden+46
  • Switzerland+41
  • Syria+963
  • São Tomé & Príncipe+239
  • Taiwan+886
  • Tajikistan+992
  • Tanzania+255
  • Thailand+66
  • Timor-Leste+670
  • Togo+228
  • Tokelau+690
  • Tonga+676
  • Trinidad & Tobago+1
  • Tunisia+216
  • Turkey+90
  • Turkmenistan+993
  • Turks & Caicos Islands+1
  • Tuvalu+688
  • U.S. Virgin Islands+1
  • Uganda+256
  • Ukraine+380
  • United Arab Emirates+971
  • United Kingdom+44
  • United States+1
  • Uruguay+598
  • Uzbekistan+998
  • Vanuatu+678
  • Vatican City+39
  • Venezuela+58
  • Vietnam+84
  • Wallis & Futuna+681
  • Western Sahara+212
  • Yemen+967
  • Zambia+260
  • Zimbabwe+263
  • Åland Islands+358

We value your privacy and keep your information secure.

Have a custom requirement? Write to us
  • In a hurry? Call us now +918042782001
  • Still searching for
    10 15 mg?

    Want customised quotation? Write to us

    Have any question or need any business consultation?

    Chat with us